AIC
SER icon

Archer Investment Corporation’s Serina Therapeutics SER Stock Holding History

Archer Investment Corporation’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3
Closed – – 529
2019
Q1 		$0 Hold
3
– – ﹤0.01% 510
2018
Q4 		$0 Buy
+3
New +$381 ﹤0.01% 472

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Archer Investment Corporation's SER Position: Q2 2019 in Review

Archer Investment Corporation sold out of Serina Therapeutics (SER) in Q2 2019, closing a stake of 3 shares.

Archer Investment Corporation first reported a position in SER in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 51 funds tracked by Wall St. Rank hold SER as of Q2 2019.

  • Archer Investment Corporation reported no remaining Serina Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Archer Investment Corporation sold 3 Serina Therapeutics shares in Q2 2019.
  • Archer Investment Corporation first reported a position in Serina Therapeutics in Q4 2018 and held it in 2 quarters.
  • Archer Investment Corporation's Serina Therapeutics position peaked at $0 in Q1 2019.
  • 51 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2019.

Based on Archer Investment Corporation's 13F filing for Q2 2019, filed 19 May 2020.